The market for microfluidic devices for neurology is forecast to grow at a CAGR of 20.1% through 2021.

The human nervous system consists of the central nervous system (CNS), which includes the brain and spinal cord, and the peripheral nervous system (PNS), which includes nerves and ganglia. The basic cell unit for the tissues forming the human nervous system is the neuron. There is growing interest in the development of technologies for the regeneration and repair of nervous tissue.

One of the most advanced technologies in this field is microfluidics. In neurology, microfluidics is applied either in vitro or in vivo to grow and isolate cells, probe functional properties of neurons, deliver treatments to diseased tissues, and regenerate the affected tissue.

A detailed summary of current and emerging applications of microfluidics in neurology is provided in the table below.  

The market for microfluidic devices for neurological applications is estimated to be valued at approximately $30 million in 2015 but it is forecast to expand at a very healthy CAGR of 20.1% through 2020.

The next table provides a list of key producers of microfluidic devices for the medical sector with special focus on neurological applications. 

Related topics: microfluidic chips for nerve injury, nervous system lab-on-chip, microfluidics for neurology, microfluidics for neurological diseases, BioMEMS for neurology, superalloys for microfluidic devices, medical electronics market

Back to Main Topics